The Neuron: AI Explained

Will AI Robots Perform Surgery Better Than Humans?

The Neuron: AI Explained

Show Notes

Autonomous surgery may sound futuristic, but automation already plays an important role in procedures requiring extraordinary precision.

Mathias Unberath of Inner Logic joins Grant Harvey to explain how AI could help surgical robots understand anatomy, respond to unexpected events, and gradually take on more responsibility in the operating room. They explore which procedures could be automated first, how robots can learn to recover from mistakes, and why these systems may expand access to care without eliminating the need for human surgeons.

For more information please visit Inner Logic: https://semaphorsurgical.com/innerlogic/

Subscribe to The Neuron newsletter: https://theneuron.ai

Sponsored by Dell Technologies and NVIDIA. Learn more at https://www.techrepublic.com/hubs/the-enterprise-guide-to-scalable-ai/

More from The Neuron: AI Explained

Oct 21, 2026

Neurosurgeon-scientists Alex Ksendzovsky and Jon Pomeraniec explain how The Biological Computing Company uses living neurons as a research platform for AI. Their team grows roughly 150,000 cells on a 4,096-electrode array, sends in patterns such as handwritten digits, records how the neurons respond, and models useful computational behaviors in software. They say those neuron-inspired techniques are already helping GPU-based video-generation systems run about 5x faster with roughly 80% lower inference cost, while their longer-term work explores robots, world models, and real-time biological compute.

Oct 16, 2026

OpenAI just dropped 20+ announcements at DevDay 2026, so... yeah, we have some things to talk about. 😺

Oct 14, 2026

Runway co-founder Anastasis Germanidis explains Solaris, an ā€œinterface world modelā€ that generates software frame by frame instead of rendering a traditional interface from HTML and CSS.

Oct 9, 2026

OpenAI DevDay 2026 is here, and we’re hosting a watch party to watch the keynote LIVE.

Oct 8, 2026

Corey and Grant sit down with Mammoth Biosciences co-founder and CEO Dr. Trevor Martin to explain how CRISPR is moving from a laboratory tool toward one-time medicines.

See all episodes →